Whoopi Goldberg Opens Up About Weight Struggles During 'Till' Filming in 2021

Whoopi Goldberg Opens Up About Weight Struggles During 'Till' Filming in 2021

Discover how Whoopi Goldberg candidly shared her weight struggles while filming the movie 'Till' in 2021, including insights into the medication she used to aid in her weight loss journey.

Whoopi Goldberg Weighed Almost 300 Pounds While Filming Till in 2021

Whoopi Goldberg Weighed Almost 300 Pounds While Filming Till in 2021

Whoopi Goldberg. Getty Images (2)

Whoopi Goldberg recently shared what motivated her to lose weight.

During a conversation about the ABC special Shame, Blame and the Weight Loss Revolution on Monday, March 18, Goldberg, who is 68 years old, opened up about her personal experience with body image.

Goldberg revealed on The View that she weighed nearly 300 pounds when she filmed Till. She mentioned that she had to take steroids and other medications during that time.

During the filming of Till, Goldberg portrayed the character of Emmett Till's grandmother Alma Carthan. She shared that she had to take steroids because of health issues related to sciatica in June 2021.

The Sister Act star confessed that her weight had fluctuated over the years, but she never let it bother her because "I don't pay attention to what others think of me."

However, Goldberg revealed that everything changed when she saw herself in Till, a film that started filming in September 2021 and was later released in the following year.

Whoopi Goldberg Weighed Almost 300 Pounds While Filming Till in 2021

Whoopi Goldberg Weighed Almost 300 Pounds While Filming Till in 2021

Whoopi Goldberg, 2021. Jamie McCarthy/Getty Images for Tribeca Festival

She explained that she had always just felt like herself. But then she saw herself and realized, “Oh, that’s a lot of me.”

Goldberg shared that she used the antidiabetic medication Mounjaro to help her “drop the weight.”

Sunny Hostin, cohost of The View, shared that she too turned to a weight loss drug during the pandemic when she gained 40 pounds.

At 55 years old, Hostin confessed, "I love cooking and discovered I love eating too much. I was shocked at the idea of appearing on air with the extra weight."

Hostin admitted that after being truthful about using Mounjaro, she faced backlash in the form of "hate emails" from individuals who accused her of depriving diabetics of the drug.

She confessed that there was a sense of shame associated with weight gain, something she had not encountered in the same way before.

Hostin appreciated the honesty of the special for recognizing obesity as a disease. She pointed out that people with diabetes or cardiac disease are not shamed for their conditions, but those who are obese often face stigma.

Hostin shared that thanks to Mounjaro, she managed to lower her cholesterol from 200 to 140. This positive change has greatly improved her overall well-being.

She expressed, "I feel better and look better now. This is truly transformative for individuals."

Editor's P/S:

Whoopi Goldberg and Sunny Hostin's candid revelations about their weight loss journeys shed light on the complex relationship between body image and personal health. Goldberg's experience of being confronted with her weight in the film "Till" prompted her to seek medical assistance, highlighting the impact of external perception on self-awareness. Hostin's use of the antidiabetic drug Mounjaro underscores the medical complexities of weight management and the need for tailored approaches.

The stigma associated with obesity, as discussed by Hostin, is a sobering reminder of the societal biases that often prevent individuals from accessing appropriate care. By sharing their stories, Goldberg and Hostin contribute to the ongoing dialogue about body positivity and the importance of addressing weight-related issues with compassion and understanding. Their experiences underscore the multifaceted nature of weight management and the need for individualized approaches that prioritize both physical and mental well-being. cholesterol levels and overall well-being highlights the potential benefits of medical interventions in certain cases. However, it is crucial to acknowledge the ethical considerations and potential risks associated with long-term use of weight loss drugs. Ultimately, the article underscores the need for a nuanced and compassionate approach to weight loss that balances personal experiences, societal pressures, and medical interventions.